The 23 analysts offering 12-month price forecasts for AstraZeneca PLC have a median target of 74.47, with a high estimate of 93.96 and a low estimate of 57.73. The median estimate represents a +15.13% increase from the last price of 64.69.
The current consensus among 28 polled investment analysts is to Buy stock in AstraZeneca PLC. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.77
Reporting Date Nov 10
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.